Video

Treatment Options for Patients with mUM Who Are Ineligible for Bispecific T-Cell Receptor Immunotherapy

Author(s):

Sunandana Chandra, MD, MS

An overview of the treatment options for patients with mUM who ineligible for treatment with tebentafusp.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Stay up to date on cancer updates, research and education

      Subscribe Now!
      Related Videos
      The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
      The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
      Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors
      Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors
      Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs
      Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs
      CLL Treatment and Quality of Life: Patient Empowerment and Shared Decision-making
      CLL Treatment and Quality of Life: Patient Empowerment and Shared Decision-making
      LL Treatment Roadmap: Navigating First-Line Options With Your Doctor
      LL Treatment Roadmap: Navigating First-Line Options With Your Doctor
      Watchful Waiting in CLL: When Waiting Is Treating
      Watchful Waiting in CLL: When Waiting Is Treating
      Connections: CLL Diagnosis: A Patient’s Perspective and Physician Insights
      Connections: CLL Diagnosis: A Patient’s Perspective and Physician Insights
      Connections: Understanding CLL: Symptoms, Diagnosis, and What Patients Need to Know
      Connections: Understanding CLL: Symptoms, Diagnosis, and What Patients Need to Know
      A panel of 3 experts on CML
      Advancing CML Management Towards an Ideal Patient Journey
      Unmet Needs and Challenges in Metastatic Uveal Melanoma
      Unmet Needs and Challenges in Metastatic Uveal Melanoma
      Related Content
      KCCure Patient Surveys Help Providers Understand Patients’ True Experiences During Treatment
      July 12th 2021

      KCCure Patient Surveys Help Providers Understand Patients’ True Experiences During Treatment

      Jamie Cesanek
      The kidney cancer advocacy organization, KCCure, has been collecting survey data on patient experiences to help bridge the communication gap between providers and patients.